Fundraising FoxHealthtech Startups
18,748 companies tagged Healthtech, with their investors and founders.
0 investors
3Spine develops MOTUS, a lumbar total joint replacement device that replaces the function of the spinal disc and facet joints as an alternative to spinal fusion for treating leg and back pain. The technology is designed to preserve range of motion and correct sagittal balance, and the company is pursuing FDA commercial approval in the US.
0 investors
0 investors
0 investors
4D Path develops a cancer diagnostics technology that combines statistical physics with cancer biology to quantify cell cycle deregulations and tumor dynamics, generating indices that predict individual patient response to therapy. It works with cancer researchers and biopharma companies to guide personalized treatment selection and support drug discovery and development.
0 investors
0 investors
4Sight Labs builds biometric monitoring systems, including its OverWatch platform, that provide real-time physiological insight into individuals in custody for correctional facilities and public-safety agencies. The systems support safety, welfare, and oversight operations in complex, steel-reinforced correctional environments.
0 investors
4WEB Medical designs titanium interbody spinal fusion implants using a truss-based structural design produced through additive manufacturing (3D printing). Its products include stand-alone and lateral spine systems intended to support the fusion process and improve patient outcomes.
0 investors
0 investors
60 Degrees Pharmaceuticals develops treatments and preventive medicines for vector-borne diseases such as babesiosis and malaria. Founded in 2010, the company focuses on tick-borne and parasitic infections affecting patients and travelers globally.
0 investors
0 investors
7 Hills Pharma is a clinical-stage drug development company developing first-in-class integrin-targeted agonists intended to improve the effectiveness of cancer immunotherapies and stem cell transplantation. Its lead molecules, Alintegimod and 7HP935, target solid tumors, hematological malignancies, and CD34+ cell-based therapies.
0 investors
0 investors
0 investors
0 investors
A28 Therapeutics develops a targeted oncolytic peptide platform for treating multiple cancer types, with its lead candidate AT-101 in late-stage development for metastatic ovarian cancer with liver metastases and hepatocellular carcinoma. The company is also exploring combinations of AT-101 with immuno-oncology drugs and chemotherapy.
0 investors
0 investors
0 investors
0 investors
0 investors
Aatru Medical is a medical device company that develops wound care products, including NPSIMS, a negative pressure wound therapy (NPWT) system for surgical incision management aimed at reducing surgical site complications. Its products serve clinicians and patients, and the company is the parent of Exothermix, which supplies the oxygen scavenger used in NPSIMS.
0 investors
0 investors
0 investors
0 investors